Skip to main content
Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
1.250
+0.020 (1.63%)
At close: Mar 9, 2026, 4:00 PM EDT
1.250
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT

Codexis Revenue

Codexis had revenue of $8.60M in the quarter ending September 30, 2025, a decrease of -32.98%. This brings the company's revenue in the last twelve months to $52.93M, down -17.87% year-over-year. In the year 2024, Codexis had annual revenue of $59.35M, down -15.39%.

Revenue (ttm)
$52.93M
Revenue Growth
-17.87%
P/S Ratio
2.06
Revenue / Employee
$281,553
Employees
188
Market Cap
112.91M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202459.35M-10.80M-15.39%
Dec 31, 202370.14M-68.45M-49.39%
Dec 31, 2022138.59M33.84M32.30%
Dec 31, 2021104.75M35.70M51.69%
Dec 31, 202069.06M598.00K0.87%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Agenus 106.83M
Fortress Biotech 62.30M
Korro Bio 7.37M
Equillium 4.39M
Coya Therapeutics 3.99M
Precision BioSciences 698.00K
Inovio Pharmaceuticals 182.34K
Genelux 8.00K
Revenue Rankings

CDXS News

More News